// App-Quantinova.ai

1224-225 : ERK5 IS A NOVEL REGULATOR OF PLATELET ACTIVATION AND CONTRIBUTES TO INFARCT EXPANSION AND CARDIAC DYSFUNCTION AFTER MYOCARDIAL INFARCTION

Researchers

Presenter

  • Scott Cameron

Principal Investigators

  • Sara Ture

  • Deanne Mickelsen

  • David Field

  • Jun-ichi Abe

  • Craig N. Morrell

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Myocardial infarction

  • Systolic dysfunction

  • Congestive heart failure

  • Coronary Artery Disease

  • Heart muscle disease

  • Twin-reversed arterial perfusion

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

  • Triiodothyronine receptor auxiliary protein

Drug/Treatment

  • Hydrogen peroxide

  • Evithrom

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved